Targeted Metabolomics for
Precise, Reliable, and Reproducible Data.
Why Analytical Quality Matters
In metabolomics, analytical data quality reflects how reliably metabolite concentrations can be measured and interpreted. High-quality data are characterized by both accuracy (results closely reflect true metabolite levels) and trustworthiness (results are consistent and reproducible across different experiments and laboratories). This reliability hinges on achieving high precision and strong reproducibility.
In many (metabolomics) research scenarios, data quality can be unequivocally more important than the sheer quantity of data points or samples. While large sample sizes are generally desirable for statistical power, if the underlying data is noisy, inaccurate, or irreproducible, even a massive dataset will lead to misleading or biased conclusions.
| Scenario | Demand for Quality |
|---|---|
| Biomarker Discovery & Validation for Diagnostics/Prognostics | High precision, accuracy, and reproducibility are critical for identifying reliable biomarkers. Low quality leads to false positives or missed true biomarkers, hindering clinical utility and regulatory approval. |
| Pharmacometabolomics & Drug Efficacy/Toxicity Studies | Even subtle metabolic changes can indicate drug effects. Inaccurate or noisy data can obscure true drug mechanisms, efficacy, or adverse events, leading to flawed drug development decisions. |
| Mechanism of Action Studies | Accurate and specific quantification of pathway intermediates and end products is essential to correctly map metabolic perturbations to specific biochemical pathways and understand underlying biological processes. |
| Clinical Trials (Later Phases: II/III) | Data quality, reproducibility, and standardization are paramount for regulatory scrutiny and informing critical decisions about drug development, patient stratification, and treatment monitoring. Results directly impact patient care. |
| Studies with Limited, Precious Samples | When samples are scarce (e.g., rare diseases, specific tissues), maximizing high-quality data from each individual sample is crucial. Poor quality would waste invaluable biological material and lead to insufficient insights. |
| Quantitative Pathway Modeling & Flux Analysis | These advanced computational analyses rely on highly accurate and precise quantification of metabolites to build reliable mathematical models and determine metabolic fluxes. Inaccurate input data generates fundamentally flawed models. |
| Multi-Center Studies | Consistency and comparability across sites are critical. Low data quality (e.g., high technical variability, different instrument performance, inconsistent protocols) across different laboratories will introduce significant batch effects and confound real biological variations, making results incomparable and invalidating conclusions despite large sample numbers. |
| Translational Research (Bench to Bedside) | Reliable translation of findings from basic research (e.g., animal models, cell lines) to human clinical applications requires robust and consistent data. Poor quality or irreproducible data at any stage can invalidate promising preclinical discoveries upon clinical testing. |
Data quality in metabolomics is a multifaceted concept, defined by meticulous attention to detail across the entire research workflow. It is determined by pre-analytical factors, encountered during initial sampling, processing and storage, where sample degradation, contamination, and heterogeneity during collection can all undermine the quality and reliability of the downstream generated analytical data. Beyond this, the quality is shaped by analytical and post-analytical parameters. These include the choice of the analytical method, the use of internal standards, accurate peak detection and integration. This is followed by the implementation of data scaling and normalization procedures which adjust for relative ranges and variance of each metabolite across all samples and mitigate batch effects. Ultimately, all of these factors, pre-, analytical and post-analytcial contribute to whether the generated data reflect biological differences rather than technical artifacts, which is vital for ensuring equal statistical weight in downstream statistical analyses.
Targeted metabolomics is an analytical approach focused on the precise measurement and quantification of a defined set of known metabolites. Unlike untargeted metabolomics—which surveys as many metabolites as possible—targeted metabolomics deliberately concentrates on specific compounds. This approach is fundamental to the quality of data generated by targeted metabolomics, providing:
Accurate and precise absolute quantitation
Reliable detection of specific metabolites
Sensitive and reproducible measurements
Robust application for clinical and research purposes
For the last 2 decades Bevital’s targeted metabolomics methods have been developed by scientists and engineers who required uncompromising quality for their own research projects. Hence, Bevital’s staff has long experience to handle pre-analytical factors as sample degradation or assay interference. Bevital’s analytical methods are publicly available and key data regarding assay precision, accuracy and sensitivity can be found in the methods section.
Analytical Quality and Statistical Power
Power calculation is a critical statistical tool used to determine the necessary sample size for a study to detect a meaningful effect if one exists. However, its application in epidemiological and clinical studies is often problematic. Many researchers neglect to perform power calculations due to a lack of awareness or the inability to estimate the required parameters. Furthermore, a major critique from experts is that power calculations are fundamentally flawed when the effect size is unknown, as is often the case in discovery-based clinical research. This can lead to inaccurate power estimates and an inappropriate sample size.
The challenges associated with statistical power, underscore the importance of high analytical quality data which minimizes measurement variability and increases confidence in results, reducing the risk of biased or misleading conclusions.
Gain in Precision by Use of Authentic Isotope-labeled Internal Standard
Bevital’s analytical platforms, which use authentic isotope-labeled internal standards (AILIS) for each analyte, consistently achieve higher assay precision than semi-targeted or untargeted methods.
Our internal standards (IS) yield median between-run coefficients of variation (CVs) as low as 2.7–5.9%. This is a stark contrast to non-authentic standards, which can result in median CVs up to 10.7 percentage points higher.
For individual platforms and analytes (A), the decrease in precision can be quite dramatic as illustrated in Figure 1 showing the assay CVs for several fat-soluble vitamins (Vit. D3, Vit. A, Vit. D2, γ-toc., α-toc., Vit. K1; authentic (x=y), non-authentic (x≠y)).
Fig. 1: Precision by different internal standards. (Click to interact)
Effect of Precision on Statistical Power
By improving precision, we can boost statistical power, which enables our customers to detect significant changes with either smaller effect sizes or in smaller sample sizes, making studies more feasible and cost-effective.
As demonstrated in Figure 2, the required sample size (N) for a study is heavily dependent on the assay’s precision, represented by the coefficient of variation (CV). The calculations are based on two-sample tests with a Type I Error () of 0.05 and a Power of 0.90. For instance, to detect a small change of just 3% (x: ratio of means), an assay with a CV of 5% requires only 57 subjects per group. However, if the CV increases to 10%, the required sample size quadruples to 226 subjects. With a CV of 20%, the number jumps to 905, and with a CV of 30%, it skyrockets to 2037 subjects per group.
As a role of thumb, a twofold decrease in assay precision necessitates a quadrupling of the study group size to maintain statistical power.
Fig. 2: Study size (N) as function of effect size (% change) for different CVs. (Click to interact)
Spurious Correlation by Use of Non-Authentic Isotope Labeled Internal Standard
Another critical advantage of AILIS is its ability to reduce spurious correlations between biologically unrelated analytes. When a single internal standard is shared among multiple analytes, its inherent variability can create a false correlation, increasing the risk of false-positive findings. This phenomenon, described by early statisticians like Pearson, Galton, and Weldon, is still often overlooked. In Figure 3, the Spearman correlation (ρ) between signal ratios A/IS of valine and serine is low () when using AILIS (green dots), correctly reflecting their biological independence. However, using a non-authentic standard inflates the correlation to , demonstrating how they can create misleading relationships in the data.
Furthermore, inadequate signal ratios of analyte to internal standard can directly compromise analytical quality. When the analyte signal is much lower than the internal standard, or vice versa, the method’s accuracy, precision, and sensitivity are at risk due to suppression, contamination, or mismatched behavior. As illustrated in the inset of Figure 3, the AILIS approach (green dots) yields a tightly grouped set of ratios centered on 1.0. In contrast, the use of various non-authentic standards (represented by purple, yellow, red, and blue dots) results in ratio distributions that deviate from this center (on a logarithmic scale). The calculated Spearman correlation coefficients for these distinct clusters further demonstrate that employing non-authentic standards leads to increased spurious correlations.
Fig. 3: Correlation between signal ratios A/IS for amino acids valine and serine using different internal standards.
Conclusion
Bevital’s targeted analytical approach, using AILIS, offer greater precision, reliability and reproducibility, enhancing statistical power, and decreasing the risk of false or misleading findings, making our platforms a powerful and trustworthy tool for basic, clinical and epidemiological research.
